This review highlights the utility of the CHA2DS2-VASc score for stroke risk stratification and the emerging role of new oral anticoagulants as effective and safer alternatives to warfarin in atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
A. John Camm (2012) conducted a review in Atrial fibrillation. Anticoagulation (warfarin and new oral anticoagulants) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: